3:
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.
Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, Zentall SS, Arnold LE, Burgess JR.
Lipids. 2003 Oct;38(10):1007-21.
PMID: 14669965 [PubMed - indexed for MEDLINE]
Related Articles
16:
Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S, Tanouchi M, Watanabe S, Hamazaki T, Terasawa K, Yazawa K.
Nutrition. 2005 Jun;21(6):705-10.
PMID: 15925295 [PubMed - indexed for MEDLINE]
Related Articles
18:
A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.
Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML, March JS, Kollins SH, Murray DW, Ravi H, Greenhill LL, Kotler LA, Paykina N, Biggins P, Stoner J.
J Child Adolesc Psychopharmacol. 2007 Apr;17(2):175-85.
PMID: 17489712 [PubMed - indexed for MEDLINE]
Related Articles